help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanghera, M. K.
Right arrow Articles by Lephart, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanghera, M. K.
Right arrow Articles by Lephart, E. D.

Endocrinology, Vol 129, 2834-2844, Copyright © 1991 by Endocrine Society


ARTICLES

Immunocytochemical distribution of aromatase cytochrome P450 in the rat brain using peptide-generated polyclonal antibodies

MK Sanghera, ER Simpson, MJ McPhaul, G Kozlowski, AJ Conley and ED Lephart
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235.

Estrogen formation is catalyzed by the aromatase cytochrome P450 (P450AROM) enzyme. Aromatase activity has been detected in several regions in the rat brain. In the present study, we used peptide- generated polyclonal antibodies raised against a 20-amino acid synthetic fragment of the rat P450AROM protein (as deduced from the nucleic acid sequence of the rat P450AROM complementary DNA), to determine the location of this enzyme in rat brain sections. Immunoreactive antisera were titered by means of an enzyme-linked immunosorbent assay and purified by diethylaminoethyl-Affigel Blue chromatography. Specific immunoreactivity was confirmed by Western blot analysis using known aromatase-containing tissue (rat ovary homogenates and microsomal fractions). Evaluation of the distribution of P450AROM immunoreactivity in brain sections of male and female rats (30 and 60 days of age) was performed using the avidin biotin peroxidase immunocytochemical technique and light microscopy. P450AROM immunoreactivity appeared to be localized to neurons, and was present in brain regions and nuclei where enzymatic activity has been reported. For example, intense immunoreactivity was observed in the amygdaloid structures and supraoptic nucleus, whereas moderate to light immunoreactivity was evident in the paraventricular and arcuate nuclei and hippocampus. Surprisingly, neurons in the bed nucleus stria terminalis, medial basal hypothalamic, and preoptic areas displayed little aromatase immunoreactivity. However, P450AROM immunoreactivity was detected in specific brain regions not previously recognized to contain the enzyme (i.e. intense staining was seen in the reticular thalamic nucleus, olfactory tract and piriform cortex, as well as other brain structures). The pattern, distribution, and intensity of P450AROM immunoreactivity was similar regardless of sex or age. In this study, microsomal preparations derived from a new brain area (i.e. the reticular thalamic nucleus; Rt) displaying P450AROM immunoreactivity were observed to contain detectable levels of aromatase enzymatic activity, as determined by the 3H2O-release assay. The activity in the Rt was inhibited by a known aromatase inhibitor, 4- hydroxyandrostenedione. These results confirm histologically the localization of P450AROM to brain regions where aromatase enzymatic activity has been detected and extend the knowledge of its location to areas previously unknown as sites of aromatase activity, which may be involved in the modulation of neuroendocrine function and reproductive behavior.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. J. Somponpun, A. K. Johnson, T. Beltz, and C. D. Sladek
Estrogen receptor-{alpha} expression in osmosensitive elements of the lamina terminalis: regulation by hypertonicity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R661 - R669.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Sierra-Ramirez, T. Morato, R. Campos, I. Rubio, C. Calzada, E. Mendez, and G. Ceballos
Acute effects of testosterone on intracellular Ca2+ kinetics in rat coronary endothelial cells are exerted via aromatization to estrogens
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H63 - H71.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O. Kretz, L. Fester, U. Wehrenberg, L. Zhou, S. Brauckmann, S. Zhao, J. Prange-Kiel, T. Naumann, H. Jarry, M. Frotscher, et al.
Hippocampal Synapses Depend on Hippocampal Estrogen Synthesis
J. Neurosci., June 30, 2004; 24(26): 5913 - 5921.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Somponpun and C. D. Sladek
Role of Estrogen Receptor-{beta} in Regulation of Vasopressin and Oxytocin Release in Vitro
Endocrinology, August 1, 2002; 143(8): 2899 - 2904.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
F. Naftolin, T. L. Horvath, and J. Balthazart
Estrogen Synthetase (Aromatase) Immunohistochemistry Reveals Concordance Between Avian and Rodent Limbic Systems and Hypothalami
Experimental Biology and Medicine, September 1, 2001; 226(8): 717 - 725.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. G. Mensah-Nyagan, J.-L. Do-Rego, D. Beaujean, V. Luu-The, G. Pelletier, and H. Vaudry
Neurosteroids: Expression of Steroidogenic Enzymes and Regulation of Steroid Biosynthesis in the Central Nervous System
Pharmacol. Rev., March 1, 1999; 51(1): 63 - 82.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Prevot, D. Croix, C. M. Rialas, P. Poulain, G. L. Fricchione, G. B. Stefano, and J.-C. Beauvillain
Estradiol Coupling to Endothelial Nitric Oxide Stimulates Gonadotropin-Releasing Hormone Release from Rat Median Eminence Via a Membrane Receptor
Endocrinology, February 1, 1999; 140(2): 652 - 659.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
R. W. Wang and A. Y. H. Lu
Inhibitory Anti-Peptide Antibody Against Human CYP3A4
Drug Metab. Dispos., June 1, 1997; 25(6): 762 - 767.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society